Bristol-Myers Squibb Company (BMY)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 75.96 |
| Open | 76.50 |
| Bid | 76.02 x 900 |
| Ask | 76.37 x 3000 |
| Day's Range | 75.34 - 77.15 |
| 52 Week Range | 53.22 - 78.47 |
| Volume | |
| Avg. Volume | 15,535,258 |
| Market Cap | 162.213B |
| Beta (5Y Monthly) | 0.48 |
| PE Ratio (TTM) | 26.99 |
| EPS (TTM) | 2.82 |
| Earnings Date | Jul 27, 2022 |
| Forward Dividend & Yield | 2.16 (2.84%) |
| Ex-Dividend Date | Mar 31, 2022 |
| 1y Target Est | 79.40 |
- Zacks
Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer
Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.
- News Direct
The Evolution of Lung Cancer Research
We have made huge strides in research across lung cancer types, stages and patient groups
- Business Wire
Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
PRINCETON, N.J., May 19, 2022--Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
© 2022 Yahoo. All rights reserved.
